PRPH stock pitch - 2023-07-25

Added to YB: 2023-07-25

Pitch date: 2023-07-25

ProPhase Labs, Inc.

current return

Author Info

No bio for this author

Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium

Company Info

ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States.

Market Cap

$6.9M

Pitch Price

$7.03

Price Target

N/A

Dividend

N/A

EV/EBITDA

-0.62

P/E

-0.11

EV/Sales

2.80

Sector

Pharmaceuticals

A summary for this pitch has not been created yet.